	MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis. Future Oncol Wang JY, Shao YX, Yang LL, Li HS, Liu JQ, Liu RZ, Zhang S, Li X, Liu JY. PMID: 42757773 [PubMed - as supplied by publisher]
	Eomesodermin in renal cell carcinoma: Epigenetic and immune crosstalk driving tumor progression (Review). Int J Oncol Che Z, Huang D, Lin J, Wang X, Feng R, Che X, Wang Y. PMID: 42757465 [PubMed - indexed for MEDLINE]
	Bridging the Resolution Gap in Recurrent Prostate Cancer Imaging: Quantum Dots as PSMA-Targeted Optical Probes. ACS Omega Gidiya Y, Chaudhary J, Biswas A, Liao M, Ramaroson M, Kamei KI. PMID: 42757093 [PubMed]
	Perioperative cognitive dysfunction in bladder cancer patients, causal factors, and possible interventions. Front Med (Lausanne) Cicvaric A, Glavas Tahtler J, Pavlovic O, Dias C, Tot OK, Bjelousov Baksa A, Kvolik S. PMID: 42756876 [PubMed]
	Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK. Eur Urol Open Sci Wang J, Almeida-Magana R, Dinneen E, Pan S, Leurent B, Roberts N, Brew-Graves C, Williams NR, Haider A, Shaw G, Pizzo E. PMID: 42755911 [PubMed]
	Adjuvant therapy in chromophobe renal cell carcinoma: current evidence and unmet needs. Front Oncol Bejjani N, Kattan J. PMID: 42755866 [PubMed]
	Performance evaluation of large language models in bladder cancer patient education Q&A: a cross-sectional study. Front Oncol Wan D, Li Y, Dong Z, Dai C, Ye J, Li S, Jiang S. PMID: 42755637 [PubMed]
	Antidiabetic drug exposure and risk of bladder cancer: A systematic review and meta-analysis. Urologia Mathez W, Vincentelli A, Chaoui I, Bruyère F, Bourgi A. PMID: 42755180 [PubMed - as supplied by publisher]
	Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study. J Int Med Res Wang F, Tian YE, Liu Q, Sha MO, Wang P, Huang X, Tuoheti K, Chen J, Cui QI. PMID: 42754412 [PubMed - indexed for MEDLINE]
	From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX-Targeted [(68)Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [(18)F]FDG PET/CT. J Nucl Med Kömek H, Arslan E, Can C, Akgün E, K, Yüceta, Akdeniz N, Çermik TF, Urakç, Do, Bardakç, Yeprem Ö, Kural AR. PMID: 42754347 [PubMed - as supplied by publisher]
	Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial. Cancer Immunol Res Rafael TS, Gil-Jimenez A, Elst L, de Vries HM, Seignette IM, Bekers E, Lopez-Yurda M, Peters D, Nieuwland M, Hooijberg E, Broeks A, Brouwer OR, Schaake EE, Lambrechts D, Wessels LFA, Vis DJ, Albersen M, de Gruijl TD, van der Heijden MS. PMID: 42754263 [PubMed - as supplied by publisher]
	Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives. J Immunol Res Shi R, Ran L, Song T, Zhou X, Zhao W, Zhang Y. PMID: 42753002 [PubMed - indexed for MEDLINE]
	Safety and patient-reported outcomes of multimodal PSMA PET/MRI-guided prostate biopsy: results from the prospective multicenter DEPROMP trial. World J Urol Schmidt CJ, Reichert T, Gaertner FC, Kreppel B, Essler M, Luetkens JA, Attenberger U, Anspach M, Ohlmann CH, Hauser S, Ellinger J, Ritter M, Krausewitz P. PMID: 42752988 [PubMed - indexed for MEDLINE]
	Multimodal large language models for bladder tumor detection in cystoscopy: a retrospective benchmarking study. World J Urol Prat Y, Mahmud H, Tsur A, Laufer M, Orkin D, Dotan ZA, Rosenzweig B. PMID: 42752986 [PubMed - indexed for MEDLINE]
	Night work and cancer risk: results from the ELSA-Brasil worker cohort. Rev Saude Publica Bernardino DCAM, Otero UB, Pimenta IT, Griep RH, Giatti L, Barreto SM, Fonseca MJMD. PMID: 42752711 [PubMed - indexed for MEDLINE]
	Perirenal fat stranding on preoperative imaging is associated with a prolonged operative time in pediatric radical nephrectomy. Pediatr Surg Int Ebihara M, Deie K, Matsuda R, Tsuzaka S, Taki S, Ogawa S, Kawashima H. PMID: 42752704 [PubMed - indexed for MEDLINE]
	Current Trends in Therapeutic Outcomes Among Patients With Metastatic Renal Cell Carcinoma of the Spine: A Systematic Review and Meta-Analysis. Global Spine J Ndika TC, Woo J, Lee BT, Johnson E, Oguguo E, Rivera N, Ray EJ, Bello A, Tiako JD, Mohamed L, Larry Lo SF, Sciubba DM, De la Garza Ramos R, O'Toole JE, Chongsathidkiet P, Dalton T, Crowell KA, Von Isenburg M, Mullikin T, Erickson M, Goodwin CR. PMID: 42751937 [PubMed - as supplied by publisher]
	Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. Cancer Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. PMID: 42751801 [PubMed - indexed for MEDLINE]
	Immunotherapy role in bladder cancer treatment: a review of literature. Front Oncol Thalambedu N, Vasipalli K, Sampath Kumar N, Vellanki S, Trikannad AK, Gullapalli M, Tu SM, Kunthur A. PMID: 42751111 [PubMed]
	Reviving cancer vaccines in renal cell carcinoma: a new chapter in immunotherapy for kidney cancer. Immunooncol Technol Scallo FM, Ishizuka JJ, Braun DA. PMID: 42751052 [PubMed]

Articles 1 - 20 / 181525

Page 1 of 9077



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy